BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal 2018;32:e22418. [PMID: 29484706 DOI: 10.1002/jcla.22418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Suszynska M, Kozlowski P. Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. Genes (Basel) 2020;11:E798. [PMID: 32679805 DOI: 10.3390/genes11070798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal 2018;32:e22418. [PMID: 29484706 DOI: 10.1002/jcla.22418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Saini G, Mittal K, Rida P, Janssen EAM, Gogineni K, Aneja R. Panoptic View of Prognostic Models for Personalized Breast Cancer Management. Cancers (Basel) 2019;11:E1325. [PMID: 31500225 DOI: 10.3390/cancers11091325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]